<--- Back to Details
First PageDocument Content
Cell lines / Galactosides / Enzymes / Gene delivery / Fabry disease / Cell culture / Alpha-galactosidase / Assay / Cytotoxicity / Biology / Chemistry / Molecular biology
Cell lines
Galactosides
Enzymes
Gene delivery
Fabry disease
Cell culture
Alpha-galactosidase
Assay
Cytotoxicity
Biology
Chemistry
Molecular biology

Genzyme STN #[removed]Date: From: To: Through/With: Product:

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 59,17 KB

Share Document on Facebook

Similar Documents

Migalastat and Enzyme Replacement Therapy Have Comparable Effects on Renal Function in Fabry Disease: Phase 3 Study Results Nicholls, K1*, Bichet, DG2, Giugliani, R3, Hughes, D4, Schiffmann, R5, Wilcox, W6, Skuban, N7, R

DocID: 1tiPw - View Document

Health / Genzyme / Sanofi / Medicine / Fabry disease / Alpha-galactosidase / Clinical medicine / Lawsuit

United States Court of Appeals For the First Circuit NoANITA HOCHENDONER ET AL., Plaintiffs, Appellants, v.

DocID: 1rtqA - View Document

Medicine / Pain / Clinical medicine / Painful fat herniation / Plantar fasciitis / PPP / Papule / Fabry disease

www.edoriumjournals.com CASE SERIES PEER REVIEWED | OPEN ACCESS

DocID: 1q86Q - View Document

Lipid storage disorders / Fabry disease / Alpha-galactosidase / Enzyme replacement therapy / Globotriaosylceramide / Placebo / Health / Medicine / Rare diseases

  The Journal of Rare Disorders CochraneCorner 

DocID: 19CDW - View Document

Peripartum cardiomyopathy / Heart diseases / Rare diseases / Heart failure / Cardiovascular disease / Fabry disease / Disease registry / Health / Medicine / Cardiomyopathy

Study Group on Peripartum Cardiomyopathy Prof. K. Sliwa (Cape Town, South Africa) Prof. B. Pieske (Graz, AT) Aims

DocID: 18N9y - View Document